Medical Developments International (MDI)
Sharie Butt is a seasoned sales professional with extensive experience in the pharmaceutical industry. Currently serving as the National Business Manager at Medical Developments International since September 2022, Sharie has previously held key roles as Regional Sales Manager at Chiesi Group and Sales Manager at GSK, specializing in respiratory sales. Sharie's career in sales management began at Sanofi, where Sharie excelled as State Manager for Diabetes while also developing as a Sales Manager. Prior experience includes a role at Pfizer as Hospital Sales Representative, where Sharie successfully launched a neurology product, significantly exceeding sales expectations. Sharie started the professional journey as a Social Worker after earning a Bachelor of Social Work from the University of Melbourne and a Bachelor of Arts in Sociology and Psychology from Monash University. Key attributes include strong leadership, innovation-driven sales strategies, and the ability to build strategic relationships.
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.